精神心理科

订阅

MedSci主页 / 所有栏目 / 精神心理科

西安杨森治疗精神分裂症长效针剂善妥达®获批！

2018-05-25 佚名 西安杨森

善妥达上市
关注

国家药品监督管理局正式批准治疗精神分裂症长效针剂 善妥达®棕榈帕利哌酮酯注射液（3个月剂型）在中国上市！



国家药品监督管理局正式批准

治疗精神分裂症长效针剂 善妥达®

棕榈帕利哌酮酯注射液（3个月剂型）

在中国上市！

适应症：用于接受过善思达®棕榈酸帕利哌酮注射液（1个月剂型）至少4个月充分治疗的精神分裂症患者。

善妥达®每年仅需注射四次

为精神分裂症患者提供一种新型治疗选择

提升用药依从性

减少由于中断药物治疗而导致的疾病复发

精神分裂症是中国面临的重大公共卫生挑战之一，对患者及其家庭以及社会带来巨大的影响。据世界卫生组织统计，全球有超过2，300万人正在遭受精神分裂症的困扰[1]。截至2016年底，中国登记在册的精神分裂症患者人数约为405万[2]。在我国，精神疾病所带来的负担已超过其他的疾病领域，约占所有疾病负担总和的20%，这一数字预计在2020年上升至25%[3]。


Asgar Rangoonwala 西安杨森制药有限公司总裁

西安杨森理解中国精神分裂症治疗中未被满足的需求和亟需应对的挑战，并致力于为正在遭受精神分裂症困扰的患者及其家庭带来积极改变，我们正在与中国残疾人福利基金会在内的合作伙伴们一道，提高善妥达®的可及性，以早日为中国的精神分裂症患者带去希望，帮助他们回归社会。

截止到2017年12月，善妥达®已在全球53个国家和地区获批。

[1] World Health Organization. schizophrenia. Fact sheet No397. April 2016 http：//www.who.int/mediacentre/factsheets/fs397/en/ Accessed September 2017

[2] 国家卫生计生委，2017年4月例行新闻发布会：全国精神卫生工作进展情况http：//www.nhfpc.gov.cn/zhuz/xwfb/201704/20cf8768e05445a387a1c4bf1be9ec6d.shtml Accessed September2017。

[3] 张伟波，等.中国医药导报.2013；10(1)：156-160


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1815100, encodeId=a9681815100a2, content=<a href='/topic/show?id=b13c969505b' target=_blank style='color:#2F92EE;'>#长效针剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96950, encryptionId=b13c969505b, topicName=长效针剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Mon Oct 15 12:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404097, encodeId=4c7f140409e51, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIXE1PadWxBeosSHpB06cC9uZflHWBnMib5rSPbq29kzxyzUPEqWfvlNl0DMmX9070Gdwbq4zwg4vg/132, createdBy=bfe92444551, createdName=bnurmamat, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424966, encodeId=14e1142496610, content=<a href='/topic/show?id=d42b90494af' target=_blank style='color:#2F92EE;'>#西安杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90494, encryptionId=d42b90494af, topicName=西安杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7a73942387, createdName=qindq, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543210, encodeId=e3f1154321093, content=<a href='/topic/show?id=f2be61592eb' target=_blank style='color:#2F92EE;'>#杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61592, encryptionId=f2be61592eb, topicName=杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=421413558235, createdName=陆成振, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318524, encodeId=9d2c318524fe, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 25 20:19:36 CST 2018, time=2018-05-25, status=1, ipAttribution=)]
    2018-10-15 ms1692212821629096

    #长效针剂#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1815100, encodeId=a9681815100a2, content=<a href='/topic/show?id=b13c969505b' target=_blank style='color:#2F92EE;'>#长效针剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96950, encryptionId=b13c969505b, topicName=长效针剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Mon Oct 15 12:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404097, encodeId=4c7f140409e51, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIXE1PadWxBeosSHpB06cC9uZflHWBnMib5rSPbq29kzxyzUPEqWfvlNl0DMmX9070Gdwbq4zwg4vg/132, createdBy=bfe92444551, createdName=bnurmamat, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424966, encodeId=14e1142496610, content=<a href='/topic/show?id=d42b90494af' target=_blank style='color:#2F92EE;'>#西安杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90494, encryptionId=d42b90494af, topicName=西安杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7a73942387, createdName=qindq, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543210, encodeId=e3f1154321093, content=<a href='/topic/show?id=f2be61592eb' target=_blank style='color:#2F92EE;'>#杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61592, encryptionId=f2be61592eb, topicName=杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=421413558235, createdName=陆成振, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318524, encodeId=9d2c318524fe, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 25 20:19:36 CST 2018, time=2018-05-25, status=1, ipAttribution=)]
    2018-05-27 bnurmamat

    #精神分裂#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1815100, encodeId=a9681815100a2, content=<a href='/topic/show?id=b13c969505b' target=_blank style='color:#2F92EE;'>#长效针剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96950, encryptionId=b13c969505b, topicName=长效针剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Mon Oct 15 12:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404097, encodeId=4c7f140409e51, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIXE1PadWxBeosSHpB06cC9uZflHWBnMib5rSPbq29kzxyzUPEqWfvlNl0DMmX9070Gdwbq4zwg4vg/132, createdBy=bfe92444551, createdName=bnurmamat, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424966, encodeId=14e1142496610, content=<a href='/topic/show?id=d42b90494af' target=_blank style='color:#2F92EE;'>#西安杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90494, encryptionId=d42b90494af, topicName=西安杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7a73942387, createdName=qindq, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543210, encodeId=e3f1154321093, content=<a href='/topic/show?id=f2be61592eb' target=_blank style='color:#2F92EE;'>#杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61592, encryptionId=f2be61592eb, topicName=杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=421413558235, createdName=陆成振, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318524, encodeId=9d2c318524fe, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 25 20:19:36 CST 2018, time=2018-05-25, status=1, ipAttribution=)]
    2018-05-27 qindq

    #西安杨森#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1815100, encodeId=a9681815100a2, content=<a href='/topic/show?id=b13c969505b' target=_blank style='color:#2F92EE;'>#长效针剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96950, encryptionId=b13c969505b, topicName=长效针剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Mon Oct 15 12:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404097, encodeId=4c7f140409e51, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIXE1PadWxBeosSHpB06cC9uZflHWBnMib5rSPbq29kzxyzUPEqWfvlNl0DMmX9070Gdwbq4zwg4vg/132, createdBy=bfe92444551, createdName=bnurmamat, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424966, encodeId=14e1142496610, content=<a href='/topic/show?id=d42b90494af' target=_blank style='color:#2F92EE;'>#西安杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90494, encryptionId=d42b90494af, topicName=西安杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7a73942387, createdName=qindq, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543210, encodeId=e3f1154321093, content=<a href='/topic/show?id=f2be61592eb' target=_blank style='color:#2F92EE;'>#杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61592, encryptionId=f2be61592eb, topicName=杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=421413558235, createdName=陆成振, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318524, encodeId=9d2c318524fe, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 25 20:19:36 CST 2018, time=2018-05-25, status=1, ipAttribution=)]
    2018-05-27 陆成振

    #杨森#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1815100, encodeId=a9681815100a2, content=<a href='/topic/show?id=b13c969505b' target=_blank style='color:#2F92EE;'>#长效针剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96950, encryptionId=b13c969505b, topicName=长效针剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Mon Oct 15 12:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404097, encodeId=4c7f140409e51, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIXE1PadWxBeosSHpB06cC9uZflHWBnMib5rSPbq29kzxyzUPEqWfvlNl0DMmX9070Gdwbq4zwg4vg/132, createdBy=bfe92444551, createdName=bnurmamat, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424966, encodeId=14e1142496610, content=<a href='/topic/show?id=d42b90494af' target=_blank style='color:#2F92EE;'>#西安杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90494, encryptionId=d42b90494af, topicName=西安杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7a73942387, createdName=qindq, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543210, encodeId=e3f1154321093, content=<a href='/topic/show?id=f2be61592eb' target=_blank style='color:#2F92EE;'>#杨森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61592, encryptionId=f2be61592eb, topicName=杨森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=421413558235, createdName=陆成振, createdTime=Sun May 27 06:21:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318524, encodeId=9d2c318524fe, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 25 20:19:36 CST 2018, time=2018-05-25, status=1, ipAttribution=)]
    2018-05-25 131****1460

    学习了受益匪浅

    0